These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 29434149)
1. Pancytopenia and Myelodysplastic Changes in Aceruloplasminemia: A Case with a Novel Pathogenic Variant in the Ceruloplasmin Gene. Yamamura A; Kikukawa Y; Tokunaga K; Miyagawa E; Endo S; Miyake H; Hata H; Mitsuya H; Yoshida K; Matsuoka M Intern Med; 2018 Jul; 57(13):1905-1910. PubMed ID: 29434149 [TBL] [Abstract][Full Text] [Related]
2. Deferasirox Might Be Effective for Microcytic Anemia and Neurological Symptoms Associated with Aceruloplasminemia: A Case Report and Review of the Literature. Miyake Z; Nakamagoe K; Yoshida K; Kondo T; Tamaoka A Intern Med; 2020 Jul; 59(14):1755-1761. PubMed ID: 32238721 [TBL] [Abstract][Full Text] [Related]
3. Teaching NeuroImages: neurodegeneration with brain iron accumulation in aceruloplasminemia. Parks NE; Vandorpe RA; Moeller JJ Neurology; 2013 Nov; 81(20):e151-2. PubMed ID: 24218322 [TBL] [Abstract][Full Text] [Related]
4. Aceruloplasminemia: Neurodegeneration with brain iron accumulation associated with psychosis. Vroegindeweij LHP; Boon AJW; Wilson JHP; Langendonk JG J Inherit Metab Dis; 2019 Mar; 42(2):195-196. PubMed ID: 30671987 [No Abstract] [Full Text] [Related]
5. Novel ceruloplasmin mutation causing aceruloplasminemia with hepatic iron overload and diabetes without neurological symptoms. Rusticeanu M; Zimmer V; Schleithoff L; Wonney K; Viera J; Zimmer A; Hübschen U; Bohle RM; Grünhage F; Lammert F Clin Genet; 2014 Mar; 85(3):300-1. PubMed ID: 23557349 [No Abstract] [Full Text] [Related]
6. Aceruloplasminemia with Abnormal Compound Heterozygous Mutations Developed Neurological Dysfunction during Phlebotomy Therapy. Watanabe M; Ohyama K; Suzuki M; Nosaki Y; Hara T; Iwai K; Kono S; Miyajima H; Mokuno K Intern Med; 2018 Sep; 57(18):2713-2718. PubMed ID: 29709961 [TBL] [Abstract][Full Text] [Related]
7. Superficial siderosis associated with aceruloplasminemia. Case report. Matsushima A; Yoshida T; Yoshida K; Ohara S; Toyoshima Y; Kakita A; Ikeda S J Neurol Sci; 2014 Apr; 339(1-2):231-4. PubMed ID: 24607334 [TBL] [Abstract][Full Text] [Related]
8. Aceruloplasminemia: An entity to consider in patients with anemia. Lozano-Varela M; Carrera-Alonso E; Plaza-Palacios G Rev Esp Enferm Dig; 2014 May; 106(5):360-1. PubMed ID: 25287242 [No Abstract] [Full Text] [Related]
9. Criteria for early identification of aceruloplasminemia. Ogimoto M; Anzai K; Takenoshita H; Kogawa K; Akehi Y; Yoshida R; Nakano M; Yoshida K; Ono J Intern Med; 2011; 50(13):1415-8. PubMed ID: 21720062 [TBL] [Abstract][Full Text] [Related]
10. Radiological Findings of Two Sisters with Aceruloplasminemia Presenting with Chorea. Kim HK; Ki CS; Kim YJ; Lee MS Clin Neuroradiol; 2017 Sep; 27(3):385-388. PubMed ID: 28258281 [No Abstract] [Full Text] [Related]
11. Extending the aceruloplasminemia phenotype: NBIA on imaging and acanthocytosis, yet only minor neurological findings. Kassubek R; Uttner I; Schönfeldt-Lecuona C; Kassubek J; Connemann BJ J Neurol Sci; 2017 May; 376():151-152. PubMed ID: 28431603 [No Abstract] [Full Text] [Related]
12. Aceruloplasminemia presents as Type 1 diabetes in non-obese adults: a detailed case series. Vroegindeweij LH; van der Beek EH; Boon AJ; Hoogendoorn M; Kievit JA; Wilson JH; Langendonk JG Diabet Med; 2015 Aug; 32(8):993-1000. PubMed ID: 25661792 [TBL] [Abstract][Full Text] [Related]
13. [Aceruloplasminemia, a rare condition not to be overlooked]. Lobbes H; Reynaud Q; Mainbourg S; Lega JC; Durieu I; Durupt S Rev Med Interne; 2020 Nov; 41(11):769-775. PubMed ID: 32682623 [TBL] [Abstract][Full Text] [Related]
14. Ceruloplasmin deficiency does not induce macrophagic iron overload: lessons from a new rat model of hereditary aceruloplasminemia. Kenawi M; Rouger E; Island ML; Leroyer P; Robin F; Rémy S; Tesson L; Anegon I; Nay K; Derbré F; Brissot P; Ropert M; Cavey T; Loréal O FASEB J; 2019 Dec; 33(12):13492-13502. PubMed ID: 31560858 [TBL] [Abstract][Full Text] [Related]
15. Molecular and pathological basis of aceruloplasminemia. Kono S; Miyajima H Biol Res; 2006; 39(1):15-23. PubMed ID: 16629161 [TBL] [Abstract][Full Text] [Related]
16. Diagnosing aceruloplasminemia: navigating through red herrings. Kharel Z; Kharel H; Phatak PD Ann Hematol; 2024 Jun; 103(6):2173-2176. PubMed ID: 38637332 [TBL] [Abstract][Full Text] [Related]
17. Central diabetes insipidus and hypothalamic hypothyroidism associated with aceruloplasminemia. Watanabe M; Asai C; Ishikawa K; Kiyota A; Terada T; Kono S; Miyajima H; Okumura A Intern Med; 2010; 49(15):1581-5. PubMed ID: 20686294 [TBL] [Abstract][Full Text] [Related]
18. Identification and in silico characterization of a novel compound heterozygosity associated with hereditary aceruloplasminemia. Hofmann WP; Welsch C; Takahashi Y; Miyajima H; Mihm U; Krick C; Zeuzem S; Sarrazin C Scand J Gastroenterol; 2007 Sep; 42(9):1088-94. PubMed ID: 17710675 [TBL] [Abstract][Full Text] [Related]
19. New mutation of the ceruloplasmin gene in the case of a neurologically asymptomatic patient with microcytic anaemia, obesity and supposed Wilson's disease. Ondrejkovičová M; Dražilová S; Drakulová M; Siles JL; Zemjarová Mezenská R; Jungová P; Fabián M; Rychlý B; Žigrai M BMC Gastroenterol; 2020 Apr; 20(1):95. PubMed ID: 32264837 [TBL] [Abstract][Full Text] [Related]
20. Case 35-2020: A 59-Year-Old Woman with Type 1 Diabetes Mellitus and Obtundation. Caplan DN; Rapalino O; Karaa A; Rosovsky RP; Uljon S N Engl J Med; 2020 Nov; 383(20):1974-1983. PubMed ID: 33176089 [No Abstract] [Full Text] [Related] [Next] [New Search]